Dizal Pharmaceuticals
688192 · SSE STAR Market
Public Market Listing
Live quotes, historical charts, and market capitalization for Dizal Pharmaceuticals are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(2 total)
| Target & Modality | |||
|---|---|---|---|
Sunvozertinib(Zegfrovy) | Approved | EGFRSmall molecule | Non-Small Cell Lung Cancer |
| Phase 1/2 | EGFRSmall molecule | Non-Small Cell Lung Cancer |
Upcoming events
(3 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
Regulatory and conference events
(4)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent